Pages that link to "Q40599604"
Jump to navigation
Jump to search
The following pages link to Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism (Q40599604):
Displaying 50 items.
- An in-depth analysis of original antigenic sin in dengue virus infection (Q24606493) (← links)
- Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay (Q26700079) (← links)
- Carbohydrate-related inhibitors of dengue virus entry (Q26864413) (← links)
- Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein (Q27472922) (← links)
- Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus (Q27484362) (← links)
- Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes (Q27485031) (← links)
- A dengue receptor as possible genetic marker of vector competence in Aedes aegypti (Q27486539) (← links)
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus (Q27486788) (← links)
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development (Q27488364) (← links)
- Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3) (Q27489953) (← links)
- Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins (Q27490500) (← links)
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 (Q27491317) (← links)
- Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins (Q27649830) (← links)
- Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity (Q27678419) (← links)
- Evasion of innate and adaptive immunity by flaviviruses (Q28204656) (← links)
- Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses (Q28729951) (← links)
- A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses (Q28741828) (← links)
- Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein (Q29618169) (← links)
- Deriving topological constraints from functional data for the design of reagentless fluorescent immunosensors (Q30764031) (← links)
- Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. (Q33220467) (← links)
- Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection (Q33425879) (← links)
- Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2. (Q33538375) (← links)
- A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein (Q33802834) (← links)
- Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains (Q34104330) (← links)
- Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. (Q34120070) (← links)
- Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses (Q34129876) (← links)
- A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein (Q34235005) (← links)
- Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins (Q34354665) (← links)
- Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus (Q34408025) (← links)
- Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody (Q34451752) (← links)
- Flavivirus structure and membrane fusion (Q35616804) (← links)
- Antigenic structure of flavivirus proteins (Q35616815) (← links)
- Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III. (Q35796610) (← links)
- Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus (Q36286276) (← links)
- Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency (Q36799290) (← links)
- The molecular basis of antibody-mediated neutralization of West Nile virus (Q36842733) (← links)
- Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice (Q37137235) (← links)
- Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine (Q37500519) (← links)
- Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses (Q37511328) (← links)
- Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway (Q37511523) (← links)
- Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein (Q37596501) (← links)
- Molecular mechanisms involved in the early steps of flavivirus cell entry (Q37792350) (← links)
- Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics. (Q38161994) (← links)
- Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2. (Q38314735) (← links)
- Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding (Q38331477) (← links)
- Key concepts, strategies, and challenges in dengue vaccine development: an opportunity for sub-unit candidates? (Q38618056) (← links)
- Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity (Q39028302) (← links)
- Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion (Q39168872) (← links)
- Genotype-specific neutralization and protection by antibodies against dengue virus type 3. (Q39668466) (← links)
- On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes (Q39876628) (← links)